The embolotherapy market in South & Central America is expected to grow from US$ 230.83 million in 2022 to US$ 339.16 million by 2028. It is estimated to grow at a CAGR of 6.6% from 2022 to 2028.

Rising Prevalence of Cancer Fuels Embolotherapy Market in South & Central America

The five most common types of cancer are breast, prostate, cervical, lung, and colorectal. However, of these five cancers, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. Embolization is used to stop bleeding or block blood flow to a tumor or abnormal area of tissue. It is also used to treat liver and kidney cancer and neuroendocrine tumors. Embolizing agents, including embolic microspheres (beads), are used to restrict the vascular supply of tumors, and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. The vascular embolization device (previously the arterial embolization device) is intended to control hemorrhaging due to aneurysms, certain types of tumors, and arteriovenous malformations. The pipeline embolization device is used for the treatment of large and giant wide-neck intracranial aneurysms in the internal carotid artery. It helps prevent aneurysms and tumors from growing and causing harm to essential organs. Thus, the rising prevalence of cancer cases is creating a high demand for embolotherapy products.

Market Overview

The embolotherapy market in South & Central America is segmented into Brazil, Argentina, and the rest of SAM . In 2021, Brazil held the largest market share. Also, the market in the country is projected to grow at the highest rate during the forecast period. The embolotherapy market in the region is expected to grow in the coming years owing to the rising prevalence of cancer and improving healthcare facilities in the countries. Brazil is the largest revenue-generating country for the embolotherapy market in South & Central America. Moreover, it is one of the fastest-growing economies across the world. Cancer is one of the primary epidemic diseases, and the number of cancer cases has doubled in the past three decades..

South & Central America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Embolotherapy Market Segmentation

The South & Central America embolotherapy market is segmented into product, disease indication, procedure, end user, and country.
Based on product, the market is segmented into embolic agents and support devices. The embolic agents segment registered the largest market share in 2022. Based on disease indication, the market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022. Based on procedure, the South & Central America embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022. Based on end user, the South & Central America embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the market is segmented into Brazil, Argentina, and Rest of SAM. Brazil dominated the market share in 2022. Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation are the leading companies operating in the embolotherapy market in the region.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Embolotherapy Market – by Product
1.3.2 South & Central America Embolotherapy Market – by Disease Indication
1.3.3 South & Central America Embolotherapy Market – by Procedure
1.3.4 South & Central America Embolotherapy Market – by End User
1.3.5 South & Central America Embolotherapy Market– By Country
2. South & Central America Embolotherapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Embolotherapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. South & Central America Embolotherapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Burgeoning Incidence of Cancer Cases
5.1.2 Broadening Patient Preference for Minimally Invasive Procedures
5.2 Market Restraints
5.2.1 Access of Other Alternative Therapies
5.3 Market Opportunity
5.3.1 Elevating Applications of Embolotherapy
5.4 Market Trend
5.4.1 Widening Use of Liquid Embolic Agents
5.5 Impact analysis
6. South & Central America Embolotherapy Market Analysis
6.1 South & Central America Embolotherapy Market Revenue Forecast and Analysis
7. South & Central America Embolotherapy Market – by Product
7.1 Overview
7.2 South & Central America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
7.3 Embolic Agents
7.3.1 Overview
7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.3 Microspheres
7.3.3.1 Overview
7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.4 Embolic Coils
7.3.4.1 Overview
7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.5 Embolic Plug Systems
7.3.5.1 Overview
7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.6 Detachable Balloons
7.3.6.1 Overview
7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.7 Liquid Embolic Agents
7.3.7.1 Overview
7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Support Devices
7.4.1 Overview
7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.3 Microcatheters
7.4.3.1 Overview
7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.4 Guidewires
7.4.4.1 Overview
7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Embolotherapy Market Analysis – by Disease Indication
8.1 Overview
8.2 South & Central America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Liver Cancer
8.3.2.1.1 Overview
8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Kidney Cancer
8.3.2.2.1 Overview
8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Other Cancers
8.3.2.3.1 Overview
8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Peripheral Vascular Diseases
8.4.1 Overview
8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Neurological Diseases
8.5.1 Overview
8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Urological and Nephrological Disorders
8.6.1 Overview
8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Gastrointestinal Disorders
8.7.1 Overview
8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Embolotherapy Market Analysis – by Procedure
9.1 Overview
9.2 South & Central America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
9.3 Transcatheter Arterial Embolization (TAE)
9.3.1 Overview
9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
9.4.1 Overview
9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Transarterial Chemoembolization (TACE)
9.5.1 Overview
9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Embolotherapy Market Analysis – By End User
10.1 Overview
10.2 South & Central America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11. South & Central America Embolotherapy Market – Country Analysis
11.1 Overview
11.1.1 South & Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
11.1.1.1 Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2 Brazil Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.1 Brazil Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.2 Brazil Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Brazil Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3.1 Brazil Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 Brazil Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 Brazil Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2 Argentina Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.1 Argentina Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.2 Argentina Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 Argentina Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3.1 Argentina Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 Argentina Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 Argentina Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 Rest of South and Central America: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Rest of SAM: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2 Rest of SAM Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.1 Rest of SAM Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.2 Rest of SAM Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 Rest of SAM Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3.1 Rest of SAM Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 Rest of SAM Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 Rest of SAM Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
12. South & Central America Embolotherapy Market –Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Boston Scientific Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Medtronic
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Acandis GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Balt USA LLC
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Stryker Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Guerbet LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Terumo Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Brazil Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 13. Argentina Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 14. Argentina Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of SAM Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of SAM Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of SAM Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of SAM Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of SAM Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of SAM Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of SAM Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 22. Organic Developments Done by Companies
Table 23. Inorganic Developments Done by Companies
Table 24. Glossary of Terms, South & Central America Embolotherapy Market

LIST OF FIGURES

Figure 1. South & Central America Embolotherapy Market Segmentation
Figure 2. South & Central America Embolotherapy Market, By Country
Figure 3. South & Central America Embolotherapy Market Overview
Figure 4. Embolic Agents Held Largest Share of Product Segment in South & Central America Embolotherapy Market
Figure 5. Embolotherapy Market in South & Central America to Show Remarkable Growth During Forecast Period
Figure 6. South & Central America Embolotherapy Market, Industry Landscape
Figure 7. South & Central America PEST Analysis
Figure 8. South & Central America Embolotherapy Market Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Embolotherapy Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. South & Central America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
Figure 11. Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. South & Central America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
Figure 22. Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. South & Central America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
Figure 32. Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. South & Central America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
Figure 36. Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. South & Central America: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 40. South & Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 41. Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Rest of SAM: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America embolotherapy market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the South & Central America embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the embolotherapy market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – South & Central America Embolotherapy Market

● Abbott Laboratories
● Boston Scientific Corporation
● Cook Medical LLC        
● Johnson & Johnson
● Medtronic
● Acandis GmbH  
● Balt USA LLC
● Stryker Corporation
● Guerbet LLC
● Terumo Corporation

At 8.8% CAGR, the South & Central America Embolotherapy Market is speculated to be worth US$ 339.16 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the South & Central America embolotherapy market was valued at US$ 230.83 million in 2022 and is expected to reach US$ 339.16 million by 2028, registering an annual growth rate of 6.6% from 2022 to 2028. Broadening patient preference for minimally invasive procedures and burgeoning incidence of cancer cases.

The number of minimally invasive surgeries is rising as patients increasingly prefer such surgeries due to their lower postoperative pain, postoperative complications, shorter hospital stays, fast recovery times, etc. Noninvasive or minimally invasive treatments are being developed as alternatives to surgery for patients with early-stage breast cancer. For instance, Trans Arterial Chemo Embolization, also known as TACE, is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma. TACE is for patients with asymptomatic and unresectable liver cancer. TACE can be used to diminish the size of the tumor and make the patient eligible for liver transplantation. It is considered an evolution from a formerly applied technique called Trans-catheter Arterial Embolization (TAE). Bleeding is a common issue in cancer patients, related to local tumor invasion, tumor angiogenesis, systemic effects of cancer, or anti-cancer treatments. TACE involves a two-step process—selective arterial occlusion restricts the blood supply to the tumor, which causes ischemic tumor necrosis, and regional chemotherapy is arranged that helps the drug to remain in the area for a prolonged period, which starts causing the therapeutic effects. Prostatic artery embolization (PAE) is also a minimally invasive therapy implemented as an elective outpatient technique for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The number of patients treated with PAE has grown in recent years. Thus, the increasing preference for minimally invasive procedures is fueling the embolotherapy market growth.

On the contrary, access of other alternative therapies.

Based on product, the South & Central America embolotherapy market is segmented into embolic agents and support devices. The embolic agents segment held 82.6% market share in 2022, embolic agents US$ 190.73 million. It is projected to garner US$ 282.36 million by 2028 to expand at 6.8% CAGR during 2022–2028. Based on Disease Indication, the South & Central America embolotherapy market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held 24.0% market share in 2022, amassing US$ 55.48 million. It is projected to garner US$ 84.02 million by 2028 to expand at 7.2% CAGR during 2022–2028. Based on procedure, the South & Central America embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization segment held 51.3% market share in 2022, amassing US$ 118.45 million. It is projected to garner US$ 177.59 million by 2028 to expand at 7.0% CAGR during 2022–2028. Based on end user, the South & Central America embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held 71.9% market share in 2022, amassing US$ 166.02 million. It is projected to garner US$ 245.48 million by 2028 to expand at 6.7% CAGR during 2022–2028. Based on country, the South & Central America embolotherapy market has been segmented into Brazil, Argentina, and Rest of SAM. Our regional analysis states that Brazil captured 62.0% market share in 2022. It was assessed at US$ 143.20 million in 2022 and is likely to hit US$ 213.89 million by 2028, exhibiting a CAGR of 6.9% during the forecast period. Key players dominating the South & Central America embolotherapy market are Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation among others.